Stay updated on Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page revision label was updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedThe revision label updated from v3.4.1 to v3.4.2. No study details or results are affected.SummaryDifference0.0%

- Check41 days agoChange DetectedAdded Revision: v3.4.1 and removed Revision: v3.4.0.SummaryDifference0.0%

- Check63 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4; there are no substantive changes to the study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check85 days agoChange DetectedThe page’s Locations section was updated to add numerous locations across the US, Australia, Canada, Europe and Asia, and several previously listed sites were removed.SummaryDifference1%

- Check113 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and may not be about the study. Revision: v3.3.2.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial page.